These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16002287)

  • 1. Phenylpyrroles, a new chemolibrary virtual screening class of 5-HT7 receptor ligands.
    Paillet-Loilier M; Fabis F; Lepailleur A; Bureau R; Butt-Gueulle S; Dauphin F; Delarue C; Vaudry H; Rault S
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3753-7. PubMed ID: 16002287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling studies focused on 5-HT7 versus 5-HT1A selectivity. Discovery of novel phenylpyrrole derivatives with high affinity for 5-HT7 receptors.
    Lepailleur A; Bureau R; Paillet-Loilier M; Fabis F; Saettel N; Lemaître S; Dauphin F; Lesnard A; Lancelot JC; Rault S
    J Chem Inf Model; 2005; 45(4):1075-81. PubMed ID: 16045303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-(2-Aminoethoxy)-N-(phenylsulfonyl)indoles as novel 5-HT6 receptor ligands.
    Zhou P; Yan Y; Bernotas R; Harrison BL; Huryn D; Robichaud AJ; Zhang GM; Smith DL; Schechter LE
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1393-6. PubMed ID: 15713394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: new high affinity ligands for the cannabinoid CB1 and CB2 receptors.
    Huffman JW; Padgett LW; Isherwood ML; Wiley JL; Martin BR
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5432-5. PubMed ID: 16889960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors.
    Wesołowska A
    Pol J Pharmacol; 2002; 54(4):327-41. PubMed ID: 12523486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of sulfonyl-containing arylalkylamines at human 5-HT6 serotonin receptors.
    Sikazwe D; Bondarev ML; Dukat M; Rangisetty JB; Roth BL; Glennon RA
    J Med Chem; 2006 Aug; 49(17):5217-25. PubMed ID: 16913710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel aminoethylbiphenyls as 5-HT7 receptor ligands.
    Paillet-Loilier M; Fabis F; Lepailleur A; Bureau R; Butt-Gueulle S; Dauphin F; Lesnard A; Delarue C; Vaudry H; Rault S
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3018-22. PubMed ID: 17419056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parallel solid-phase synthesis and characterization of new sulfonamide and carboxamide proline derivatives as potential CNS agents.
    Zajdel P; Subra G; Bojarski AJ; Duszyńska B; Pawłowski M; Martinez J
    Bioorg Med Chem; 2005 Apr; 13(8):3029-35. PubMed ID: 15781412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides, a class of 5-HT7 receptor agents. 2.
    Leopoldo M; Lacivita E; Contino M; Colabufo NA; Berardi F; Perrone R
    J Med Chem; 2007 Aug; 50(17):4214-21. PubMed ID: 17649988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity.
    Medina RA; Sallander J; Benhamú B; Porras E; Campillo M; Pardo L; López-Rodríguez ML
    J Med Chem; 2009 Apr; 52(8):2384-92. PubMed ID: 19326916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoalkyl phenyl sulfones--a novel series of 5-HT7 receptor ligands.
    Raubo P; Beer MS; Hunt PA; Huscroft IT; London C; Stanton JA; Kulagowski JJ
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1255-8. PubMed ID: 16337790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: structure-activity relationship elucidation.
    Peters JU; Lübbers T; Alanine A; Kolczewski S; Blasco F; Steward L
    Bioorg Med Chem Lett; 2008 Jan; 18(1):256-61. PubMed ID: 17998160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel 5-HT7 receptor inverse agonists. Synthesis and molecular modeling of arylpiperazine- and 1,2,3,4-tetrahydroisoquinoline-based arylsulfonamides.
    Vermeulen ES; van Smeden M; Schmidt AW; Sprouse JS; Wikström HV; Grol CJ
    J Med Chem; 2004 Oct; 47(22):5451-66. PubMed ID: 15481983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzothiophenes containing a piperazine side chain as selective ligands for the estrogen receptor alpha and their bioactivities in vivo.
    Yang C; Xu G; Li J; Wu X; Liu B; Yan X; Wang M; Xie Y
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1505-7. PubMed ID: 15713417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel quinazolinone derivatives as 5-HT7 receptor ligands.
    Na YH; Hong SH; Lee JH; Park WK; Baek DJ; Koh HY; Cho YS; Choo H; Pae AN
    Bioorg Med Chem; 2008 Mar; 16(5):2570-8. PubMed ID: 18083580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of modifications in imide fragment structure on 5-HT(1A) and 5-HT(7) receptor affinity and in vivo pharmacological properties of some new 1-(m-trifluoromethylphenyl)piperazines.
    Paluchowska MH; Bugno R; Duszyńska B; Tatarczyńska E; Nikiforuk A; Lenda T; Chojnacka-Wójcik E
    Bioorg Med Chem; 2007 Nov; 15(22):7116-25. PubMed ID: 17825569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-(2-Aminoethyl)-3-(arylsulfonyl)-1H-indoles as novel 5-HT6 receptor ligands.
    Bernotas R; Lenicek S; Antane S; Zhang GM; Smith D; Coupet J; Harrison B; Schechter LE
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5499-502. PubMed ID: 15482912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine/serotonin receptor ligands. 10: SAR Studies on azecine-type dopamine receptor ligands by functional screening at human cloned D1, D2L, and D5 receptors with a microplate reader based calcium assay lead to a novel potent D1/D5 selective antagonist.
    Hoefgen B; Decker M; Mohr P; Schramm AM; Rostom SA; El-Subbagh H; Schweikert PM; Rudolf DR; Kassack MU; Lehmann J
    J Med Chem; 2006 Jan; 49(2):760-9. PubMed ID: 16420061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel, potent, and selective quinoxaline-based 5-HT(3) receptor ligands. 1. Further structure-activity relationships and pharmacological characterization.
    Butini S; Budriesi R; Hamon M; Morelli E; Gemma S; Brindisi M; Borrelli G; Novellino E; Fiorini I; Ioan P; Chiarini A; Cagnotto A; Mennini T; Fracasso C; Caccia S; Campiani G
    J Med Chem; 2009 Nov; 52(21):6946-50. PubMed ID: 19831400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaproget.
    Fensome A; Bender R; Chopra R; Cohen J; Collins MA; Hudak V; Malakian K; Lockhead S; Olland A; Svenson K; Terefenko EA; Unwalla RJ; Wilhelm JM; Wolfrom S; Zhu Y; Zhang Z; Zhang P; Winneker RC; Wrobel J
    J Med Chem; 2005 Aug; 48(16):5092-5. PubMed ID: 16078826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.